184 related articles for article (PubMed ID: 31004398)
1. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.
Thapa D; Xie B; Manning JR; Zhang M; Stoner MW; Huckestein BR; Edmunds LR; Zhang X; Dedousis NL; O'Doherty RM; Jurczak MJ; Scott I
Physiol Rep; 2019 Apr; 7(8):e14043. PubMed ID: 31004398
[TBL] [Abstract][Full Text] [Related]
2. The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity.
Gao S; Ghoshal S; Zhang L; Stevens JR; McCommis KS; Finck BN; Lopaschuk GD; Butler AA
J Biol Chem; 2019 Sep; 294(36):13366-13377. PubMed ID: 31324719
[TBL] [Abstract][Full Text] [Related]
3. Adropin deficiency is associated with increased adiposity and insulin resistance.
Ganesh Kumar K; Zhang J; Gao S; Rossi J; McGuinness OP; Halem HH; Culler MD; Mynatt RL; Butler AA
Obesity (Silver Spring); 2012 Jul; 20(7):1394-402. PubMed ID: 22318315
[TBL] [Abstract][Full Text] [Related]
4. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.
Gao S; McMillan RP; Zhu Q; Lopaschuk GD; Hulver MW; Butler AA
Mol Metab; 2015 Apr; 4(4):310-24. PubMed ID: 25830094
[TBL] [Abstract][Full Text] [Related]
6. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction.
Banerjee S; Ghoshal S; Stevens JR; McCommis KS; Gao S; Castro-Sepulveda M; Mizgier ML; Girardet C; Kumar KG; Galgani JE; Niehoff ML; Farr SA; Zhang J; Butler AA
J Biol Chem; 2020 Oct; 295(40):13753-13768. PubMed ID: 32727846
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
McGrath KC; Li X; Twigg SM; Heather AK
PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
[TBL] [Abstract][Full Text] [Related]
9. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
[TBL] [Abstract][Full Text] [Related]
10. Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice.
Thapa D; Xie B; Zhang M; Stoner MW; Manning JR; Huckestein BR; Edmunds LR; Mullett SJ; McTiernan CF; Wendell SG; Jurczak MJ; Scott I
J Mol Cell Cardiol; 2019 Apr; 129():174-178. PubMed ID: 30822408
[TBL] [Abstract][Full Text] [Related]
11. Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.
Alkhalidy H; Moore W; Wang A; Luo J; McMillan RP; Wang Y; Zhen W; Hulver MW; Liu D
J Nutr Biochem; 2018 Aug; 58():90-101. PubMed ID: 29886193
[TBL] [Abstract][Full Text] [Related]
12. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
[TBL] [Abstract][Full Text] [Related]
13. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
14. Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum.
Skrzypski M; Kołodziejski PA; Pruszyńska-Oszmałek E; Wojciechowicz T; Janicka P; Krążek M; Małek E; Strowski MZ; Nowak KW
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077198
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
[TBL] [Abstract][Full Text] [Related]
16. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
17. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet alters PAS kinase regulation by fasting and feeding in liver.
Pérez-García A; Dongil P; Hurtado-Carneiro V; Blázquez E; Sanz C; Álvarez E
J Nutr Biochem; 2018 Jul; 57():14-25. PubMed ID: 29649689
[TBL] [Abstract][Full Text] [Related]
19. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
20. Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice.
Waterman C; Rojas-Silva P; Tumer TB; Kuhn P; Richard AJ; Wicks S; Stephens JM; Wang Z; Mynatt R; Cefalu W; Raskin I
Mol Nutr Food Res; 2015 Jun; 59(6):1013-24. PubMed ID: 25620073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
